Evaluation of the efficacy of aprepitant on the prevention of chemotherapy-induced nausea and vomiting and quality of life with functional living index emesis.

Aksu G., Dolasik I., Ensaroglu F., Sener S. Y., Aydin F. H., Temiz S., ...Daha Fazla

Balkan medical journal, cilt.30, sa.1, ss.64-7, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.5152/balkanmedj.2012.087
  • Dergi Adı: Balkan medical journal
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.64-7
  • Anahtar Kelimeler: Aprepitant, emezis, quality-of life, FLIE, chemotherapy, ANTAGONIST APREPITANT, CISPLATIN
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Objective: Functional Living Index Emesis (FLIE) is developed to evaluate the relationship between emesis and it's effects on patient's daily life and is far more relevant to detect the effectiveness of antiemetic treatment compared with self-diary reports. In this study, the efficacy of oral neurokinin-1 antagonist aprepitant on the prevention of chemotherapy-induced nausea and vomiting and quality of life is evaluated with FLIE.